Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
Premis Ciutat de Barcelona – 2024
The Ciutat de Barcelona Awards, granted by the Barcelona City Council, aim to recognise artistic and cultural creation linked to…
Premios Rei Jaume I – 2024
Three ICREA Research Professors received the Premio Rei Jaume I in the 37th edition of this award. Congratulation to: ยท…